Calculating utility decrements associated with an adverse event: Marginal tobit and CLAD coefficients should be used with caution

Medical Decision Making

Volumn 31, Issue 6, 2011, Pages 790-799

  Pullenayegum, Eleanor M ^a,b   Tarride, Jean Eric ^a,b   Xie, Feng ^a,b   O'Reilly, Daria ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Bayesian meta analysis; Bayesian statistical method; economic analysis (general); logistic regression models; propensity scores; survival analysis

Indexed keywords

ARTICLE; HUMAN; QUALITY OF LIFE; THEORETICAL MODEL;

HUMANS; MODELS, THEORETICAL; QUALITY OF LIFE;

EID: 85047688061     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X10393284     Document Type: Article

References (24)

1. Clarke PM, Gray AM, Briggs A, Farmer AJ, Fenn P, Stevens RJ, et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia. 2004; 47 (10). 1747-59 (Pubitemid 40022410)
2. Braithwaite RS, Goulet J, Kudel I, Tsevat J, Justice AC. Quantifying the decrement in utility from perceived side effects of combination antiretroviral therapies in patients with HIV. Value Health. 2008; 11 (5). 975-9
3. Franks P, Hanmer J, Fryback DG. Relative disutilities of 47 risk factors and conditions assessed with seven preference-based health status measures in a national U.S. sample: toward consistency in cost-effectiveness analyses. Med Care. 2006; 44 (5). 478-85 (Pubitemid 43755428)
4. Kortt MA, Clarke PM. Estimating utility values for health states of overweight and obese individuals using the SF-36. Qual Life Res. 2005; 14 (10). 2177-85 (Pubitemid 41674420)
5. Sullivan PW, Ghushchyan V. Preference-based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006; 26 (4). 410-20 (Pubitemid 44050845)
6. Sullivan PW, Lawrence WF, Ghushchyan V. A national catalog of preference-based scores for chronic conditions in the United States. Med Care. 2005; 43 (7). 736-49 (Pubitemid 40993769)
7. Austin PC. A comparison of methods for analyzing health-related quality-of-life measures. Value Health. 2002; 5 (4). 329-337 (Pubitemid 36998745)
8. Gold MR, Siegel JE, Russell LB, Weinstein MC Oxford, UK: Oxford University Press; 1996 :
9. PullenayegumEMTarrideJEXieFGoereeRGersteinHCO'ReillyD. Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate?Value Health. Forthcoming.
10. Hahl J, Hamalainen H, Simell T, Simell O. The effects of type 1 diabetes and its long-term complications on physical and mental health status. Pharmacoeconomics. 2006; 24 (6). 559-69 (Pubitemid 43886267)
11. Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making. 2002; 22 (4). 340-9 (Pubitemid 34791321)
12. Saarni SI, Joutsenniemi K, Koskinen S, Suvisaari J, Pirkola S, Sintonen H, et al. Alcohol consumption, abstaining, health utility, and quality of life-a general population survey in Finland. Alcohol Alcohol. 2008; 43 (3). 376-86 (Pubitemid 351676362)
13. Saarni SI, Suvisaari J, Sintonen H, Koskinen S, Harkanen T, Lonnqvist J. The health-related quality-of-life impact of chronic conditions varied with age in general population. J Clin Epidemiol. 2007; 60 (12). 1288-97
14. Saarni SI, Suvisaari J, Sintonen H, Pirkola S, Koskinen S, Aromaa A, et al. Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry. 2007; 190: 326-32 (Pubitemid 46580682)
15. McDonald JF, Moffitt RA. The uses of Tobit analysis. Rev Econ Stat. 1980; 62 (2). 318-21
16. Ware JE, Kosinski M, Bjorner JB 36 v2 Health Survey. 2nd ed.Lincoln, RI: Quality Metric; 2007. Lincoln, RI: Quality Metric; 2007 :
17. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988; 15 (12). 1833-40 (Pubitemid 19037656)
18. Tobin J. Estimation of relationships for limited dependent variables. Econometrica. 1958; 26: 24-36
19. O'Reilly D, Xie F, Pullenayegum EM, Gerstein HC, Blackhouse GK, Tarride JE, et al Quality of Life Research.
20. PowellJL. Least absolute deviations estimation for the censored regression model. J Econom.1984;25:303-25.
21. Greene W. Marginal effects in the censored regression model. Econ Lett. 1999; 64: 43-9
22. Austin PC, Escobar M, Kopec JA. The use of the Tobit model for analyzing measures of health status. Qual Life Res. 2000; 9: 901-10 (Pubitemid 32210184)
23. Grootendorst P. Censoring in statistical models of health status: what happens when one can do better than "1.". Qual Life Res. 2000; 9: 911-4 (Pubitemid 32210185)
24. Huang IC, Frangakis C, Atkinson MJ, Willke RJ, Leite WL, Vogel WB, et al. Addressing ceiling effects in health status measures: a comparison of techniques applied to measures for people with HIV disease. Health Serv Res. 2008; 43 (1 Pt 1). 327-39 (Pubitemid 351601519)